SCHEMBL31624497

SCHEMBL31624497

O=C(NCCCC[C@H](NC(=O)OCc1ccccc1)C(=O)OC(c1ccccc1)(c1ccccc1)c1ccccc1Cl)OCC1c2ccccc2-c2ccccc21

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 1/20 0.48
▸ HDAC2 Q92769 1/20 0.48
▸ KMT2A Q03164 1/20 0.47
▸ TGM2 P21980 2/20 0.44
▸ TGM6 O95932 1/20 0.44
▸ F13A1 P00488 1/20 0.44
▸ TGM1 P22735 1/20 0.44
▸ FOLH1 Q04609 2/20 0.43
▸ KLK7 P49862 1/20 0.43
▸ KLK5 Q9Y337 1/20 0.43
▸ SIRT2 Q8IXJ6 1/20 0.41
▸ SIRT1 Q96EB6 1/20 0.41
▸ SIRT3 Q9NTG7 1/20 0.41
▸ TLR2 O60603 1/20 0.41
▸ TLR1 Q15399 1/20 0.41
▸ MMP2 P08253 1/20 0.41
▸ MMP9 P14780 1/20 0.41
▸ SIRT5 Q9NXA8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31624368 1.00 HDAC1 (0.48) HDAC1HDAC2KMT2ATGM2TGM6
SCHEMBL31624506 0.93 KLK7 (0.48) HDAC1HDAC2KLK7KLK5SIRT2
SCHEMBL31624378 0.92 HDAC1 (0.42) HDAC1HDAC2KMT2ATGM2TGM6
SCHEMBL31624377 0.92 HDAC1 (0.42) HDAC1HDAC2KMT2ATGM2TGM6
SCHEMBL13049087 0.90 TLR2 (0.47) KMT2AKLK7KLK5TLR2TLR1
SCHEMBL31624560 0.87 SIRT2 (0.46) HDAC1HDAC2KLK7KLK5SIRT2
SCHEMBL15893676 0.87 TLR2 (0.45) KMT2ATLR2TLR1
SCHEMBL31624468 0.85 TLR2 (0.40) HDAC1HDAC2TGM2TGM6F13A1
SCHEMBL17946769 0.84 KLK7 (0.56) HDAC1HDAC2KMT2AFOLH1KLK7
SCHEMBL29370367 0.84 KLK7 (0.56) HDAC1HDAC2KMT2AFOLH1KLK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025128626-A1 HYBRID PEPTIDE COMPOUNDS HAVING A MODIFIED LYSINE RESIDUE CARMOT THERAPEUTICS, INC. (US) 2025-06-19 — — WO disclosed
WO-2025128624-A2 HYBRID PEPTIDE COMPOUNDS HAVING A SUBSTITUTED TRYPTOPHAN RESIDUE OR A TERMINAL SUBSTITUENT CARMOT THERAPEUTICS, INC. (US) 2025-06-19 — — WO disclosed
Send feedback